The NPA has issued a brief guide to the EU Falsified Medicines Directive, in the light of growing concerns about a lack of publicly available information from official channels.  The Directive, which has been introduced to reduce the risk of counterfeit medicines in the supply chain, comes into force on 9 February 2019.

Raj Patel, NPA Board Member said: “As it stands, we are still awaiting crucial details from government about the final shape of FMD.  We also need guidance about the position post-Brexit and assurances on funding. 

"This means that the pharmacy sector can’t yet make major investment decisions in relation to FMD.  In turn, this makes a February 2019 implementation date challenging, to say the least.  Unless the government fills the information gap soon, a challenging deadline will become an impossible deadline.”    

To view the guide click here.

Recommended

Order line changes at Alliance Healthcare

Retail customers should now call 0330 100 0448.

BBC investigates pharmacy workload pressures

Staffing levels in Boots UK pharmacies were explored following concerns raised by a former Boots employee.